Skip to content

Prevalence of Chapman Reflex Points in Medical Students and Their Association With Visceral Symptoms

Prevalence of Chapman Reflex Points in Medical Students and Their Association With Visceral Symptoms

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07691112
Enrollment
101
Registered
2026-07-08
Start date
2020-03-04
Completion date
2026-06-27
Last updated
2026-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autonomic Nervous System Diseases, Chapman Reflex Points, Healthy, Lymphatic Diseases, Somatic Dysfunction

Keywords

Chapman Reflex Points, Chapman Reflexes, Somatic Dysfunction, Viscerosomatic Reflexes, Osteopathic Medicine, Osteopathic Manipulative Medicine, Fascial Tissue, Myofibroblasts, Lymphatic System, Lymphatic Physiology, Autonomic Nervous System, Sympathetic Nervous System, Neuroendocrine Regulation, Mechanotransduction, Connective Tissue, Palpatory Examination, Visceral Symptoms, Fascia, Preventive Medicine

Brief summary

Chapman Reflex Points (CRPs) are small palpable nodules found within connective tissue that have traditionally been associated with dysfunction of internal organs and the autonomic nervous system. However, little is known about how commonly these findings occur in healthy individuals or whether they are associated with symptoms experienced by otherwise healthy people. The purpose of this study is to determine the prevalence of Chapman Reflex Points in young healthy adults and to evaluate whether the presence and distribution of these points are associated with self-reported visceral symptoms. Participants complete a standardized health questionnaire regarding recent and recurrent symptoms and undergo a blinded physical examination of established Chapman Reflex Point locations performed by a trained investigator. The results of this study may improve understanding of the physiological mechanisms underlying Chapman Reflex Points and help clarify their potential role in preventive osteopathic assessment and early identification of altered autonomic, lymphatic, fascial, or neuroendocrine function.

Detailed description

Chapman Reflex Points (CRPs) are discrete palpable nodules located within deep fascial tissues that have historically been interpreted as viscerosomatic reflex manifestations associated with dysfunction of specific internal organs. Traditional osteopathic models suggest that CRPs develop secondary to altered autonomic activity and lymphatic dysfunction resulting from visceral pathology. More recent mechanobiological investigations have proposed that fascial contractility mediated by myofibroblasts, sympathetic regulation of lymphatic vessel function, connective tissue remodeling, and neuroendocrine influences may contribute to the formation and persistence of these palpable findings. Despite their longstanding use in osteopathic diagnosis and treatment, there is limited evidence regarding the prevalence of CRPs in healthy individuals, and relatively few studies have investigated whether the presence of CRPs correlates with self-reported visceral symptoms in populations without significant underlying disease. Improved characterization of CRP prevalence and symptom associations may provide insight into whether these findings represent markers of overt pathology, subclinical physiological modulation, or normal biological variation. This study was designed as a cross-sectional observational investigation to evaluate the prevalence and distribution of CRPs in a young adult population and to explore potential relationships between CRP findings and participant-reported visceral symptoms. Participants completed a standardized health questionnaire designed to assess demographic characteristics, medical history, lifestyle factors, and recent or recurrent symptoms across multiple organ systems. Following questionnaire completion, participants underwent a systematic palpatory examination of established Chapman Reflex Point locations performed by a single trained investigator who was blinded to questionnaire responses. Consistent palpatory techniques, including standardized pressure application and examination duration, were utilized to improve examination reproducibility. Participant data were recorded using anonymized study identification numbers to maintain confidentiality. Statistical analyses were performed using Microsoft Excel and STATA software. Descriptive statistics were used to characterize participant demographics and CRP prevalence. Sex-based differences in total CRP counts were evaluated using Welch's two-sample t-test. Associations between individual Chapman Reflex Points and symptom clusters were assessed using stepwise regression analyses, while relationships between grouped CRPs and grouped visceral symptom scores were examined using bivariate linear regression techniques. Statistical significance was defined as a two-sided p-value of less than 0.05. The findings from this study are intended to contribute to a contemporary understanding of Chapman Reflex Point physiology by integrating concepts related to autonomic regulation, lymphatic function, fascial mechanotransduction, and endocrine modulation. Further investigation may help clarify the potential utility of CRPs as markers of early physiological alterations and inform their role in preventive osteopathic assessment and individualized patient evaluation.

Interventions

PROCEDUREChapman Reflex Point Examination

Participants underwent a standardized palpatory examination of established Chapman Reflex Point locations performed by a single trained investigator who was blinded to questionnaire responses. Consistent pressure application and examination duration were utilized to optimize reliability and reproducibility of palpatory findings. No therapeutic intervention, osteopathic manipulative treatment, medication administration, or other clinical intervention was provided as part of the study. Participants also completed a standardized health questionnaire assessing demographic characteristics, medical history, lifestyle factors, and recent or recurrent visceral symptoms.

Sponsors

The Touro College and University System
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adults aged 18 years or older. * Ability to understand the study procedures and provide informed consent. * Willingness to complete a standardized health questionnaire. * Willingness to undergo a blinded palpatory examination of established Chapman Reflex Point locations.

Exclusion criteria

* Individuals younger than 18 years of age. * Inability or unwillingness to provide informed consent. * Inability or unwillingness to complete the health questionnaire. * Inability or unwillingness to undergo the palpatory examination. * Pregnancy. * Incomplete study data or questionnaire responses.

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of Chapman Reflex Pointsthrough study completion, an average of 1 yearThe prevalence and distribution of Chapman Reflex Points identified during a standardized palpatory examination of established Chapman Reflex Point locations performed by a blinded trained investigator. The total number of Chapman Reflex Points observed per participant was recorded and summarized using descriptive statistics.

Secondary

MeasureTime frameDescription
Association Between Chapman Reflex Points and Visceral Symptom Clustersthrough study completion, an average of 1 yearAssociations between organ system-specific Chapman Reflex Point counts and self-reported visceral symptom clusters were evaluated using stepwise regression analyses and bivariate linear regression models.
Sex Differences in Chapman Reflex Point Prevalencethrough study completion, an average of 1 yearDifferences in the total number of Chapman Reflex Points identified among male and female participants were assessed using Welch's two-sample t-test.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 9, 2026